Search Results
Search for other papers by Vera Tiedje in
Google Scholar
PubMed
Search for other papers by Martin Stuschke in
Google Scholar
PubMed
Search for other papers by Frank Weber in
Google Scholar
PubMed
Search for other papers by Henning Dralle in
Google Scholar
PubMed
Search for other papers by Laura Moss in
Google Scholar
PubMed
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) is an orphan disease responsible for most thyroid carcinoma-associated deaths. Incidence is estimated to be 1–2 per million per year ( Smallridge et al . 2012 ). The histological diagnosis of
Search for other papers by Haleh Vosgha in
Google Scholar
PubMed
Search for other papers by Armin Ariana in
Google Scholar
PubMed
Genomics Research Centre, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia
Search for other papers by Robert Anthony Smith in
Google Scholar
PubMed
Search for other papers by Alfred King-yin Lam in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma is one of the most aggressive and chemotherapy-resistant types of all thyroid carcinomas. The majority of patients with anaplastic thyroid carcinoma die within a year of diagnosis ( Lo et al . 1999
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’, Institute of Biology and Molecular Genetics, Department of Surgery, Human Thyroid Cancers Preclinical and Translational Research Program, Department of Pathology, Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, ‘L. Califano’, Universita' Federico II, Napoli, Italy
Search for other papers by Roberto Bellelli in
Google Scholar
PubMed
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’, Institute of Biology and Molecular Genetics, Department of Surgery, Human Thyroid Cancers Preclinical and Translational Research Program, Department of Pathology, Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, ‘L. Califano’, Universita' Federico II, Napoli, Italy
Search for other papers by Maria Domenica Castellone in
Google Scholar
PubMed
Search for other papers by Ginesa Garcia-Rostan in
Google Scholar
PubMed
Search for other papers by Clara Ugolini in
Google Scholar
PubMed
Search for other papers by Carmelo Nucera in
Google Scholar
PubMed
Search for other papers by Peter M Sadow in
Google Scholar
PubMed
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’, Institute of Biology and Molecular Genetics, Department of Surgery, Human Thyroid Cancers Preclinical and Translational Research Program, Department of Pathology, Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, ‘L. Califano’, Universita' Federico II, Napoli, Italy
Search for other papers by Tito Claudio Nappi in
Google Scholar
PubMed
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’, Institute of Biology and Molecular Genetics, Department of Surgery, Human Thyroid Cancers Preclinical and Translational Research Program, Department of Pathology, Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, ‘L. Califano’, Universita' Federico II, Napoli, Italy
Search for other papers by Paolo Salerno in
Google Scholar
PubMed
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’, Institute of Biology and Molecular Genetics, Department of Surgery, Human Thyroid Cancers Preclinical and Translational Research Program, Department of Pathology, Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, ‘L. Califano’, Universita' Federico II, Napoli, Italy
Search for other papers by Maria Carmela Cantisani in
Google Scholar
PubMed
Search for other papers by Fulvio Basolo in
Google Scholar
PubMed
Search for other papers by Tomas Alvarez Gago in
Google Scholar
PubMed
Search for other papers by Giuliana Salvatore in
Google Scholar
PubMed
Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale ‘G. Salvatore’, Institute of Biology and Molecular Genetics, Department of Surgery, Human Thyroid Cancers Preclinical and Translational Research Program, Department of Pathology, Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, ‘L. Califano’, Universita' Federico II, Napoli, Italy
Search for other papers by Massimo Santoro in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) is a rare tumor that accounts for 2–5% of all thyroid cancers. ATC ranks among the most lethal solid malignancies with a mean survival rate of 4–12 months after diagnosis. ATC usually presents between
Search for other papers by Alyaksandr V Nikitski in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Search for other papers by Esra Karslioglu-French in
Google Scholar
PubMed
Search for other papers by Sally E Carty in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
differentiated carcinoma (PDC); and (iii) anaplastic (undifferentiated) carcinoma (AC) ( Lloyd et al. 2017 ). Although the less differentiated cancers (PDC and AC) constitute less than 5% of all thyroid malignancies, they are the most lethal types of thyroid
Search for other papers by Carmela Passaro in
Google Scholar
PubMed
Search for other papers by Antonella Abagnale in
Google Scholar
PubMed
Search for other papers by Silvana Libertini in
Google Scholar
PubMed
Search for other papers by Massimiliano Volpe in
Google Scholar
PubMed
Search for other papers by Ginevra Botta in
Google Scholar
PubMed
Search for other papers by Laura Cella in
Google Scholar
PubMed
Search for other papers by Roberto Pacelli in
Google Scholar
PubMed
Search for other papers by Gunnel Halldèn in
Google Scholar
PubMed
Search for other papers by David Gillespie in
Google Scholar
PubMed
Search for other papers by Giuseppe Portella in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) represents one of the most aggressive human malignancies. It arises from thyroid follicular cells showing morphological features of a malignant neoplasm, high proliferation rate, and marked aneuploidy
Search for other papers by Yeon-Sook Choi in
Google Scholar
PubMed
Search for other papers by Hyemi Kwon in
Google Scholar
PubMed
Search for other papers by Mi-Hyeon You in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) is a rare type of thyroid cancer with highly aggressive clinical features ( Kebebew et al. 2005 , Kurata et al. 2016 , Subbiah et al. 2018 , Lee & Park 2021 ). The median overall survival
Search for other papers by Enke Baldini in
Google Scholar
PubMed
Search for other papers by Chiara Tuccilli in
Google Scholar
PubMed
Search for other papers by Natalie Prinzi in
Google Scholar
PubMed
Search for other papers by Salvatore Sorrenti in
Google Scholar
PubMed
Search for other papers by Alessandro Antonelli in
Google Scholar
PubMed
Search for other papers by Lucio Gnessi in
Google Scholar
PubMed
Search for other papers by Stefania Morrone in
Google Scholar
PubMed
Search for other papers by Costanzo Moretti in
Google Scholar
PubMed
Search for other papers by Marco Bononi in
Google Scholar
PubMed
Search for other papers by Yannick Arlot-Bonnemains in
Google Scholar
PubMed
Search for other papers by Massimino D'Armiento in
Google Scholar
PubMed
Search for other papers by Salvatore Ulisse in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive form of thyroid cancer and overall one of the most deadly cancers, unresponsive to any available radio- and chemotherapy ( Smallridge et al . 2012 ). On presentation
Department of Pharmaco-Biology, Centro Sanitario, Department of Cellular Biology, Faculty of Pharmacy, University of Calabria, 87036 Arcavacata di Rende (Cosenza), Italy
Search for other papers by D Bonofiglio in
Google Scholar
PubMed
Search for other papers by H Qi in
Google Scholar
PubMed
Search for other papers by S Gabriele in
Google Scholar
PubMed
Department of Pharmaco-Biology, Centro Sanitario, Department of Cellular Biology, Faculty of Pharmacy, University of Calabria, 87036 Arcavacata di Rende (Cosenza), Italy
Search for other papers by S Catalano in
Google Scholar
PubMed
Department of Pharmaco-Biology, Centro Sanitario, Department of Cellular Biology, Faculty of Pharmacy, University of Calabria, 87036 Arcavacata di Rende (Cosenza), Italy
Search for other papers by S Aquila in
Google Scholar
PubMed
Search for other papers by M Belmonte in
Google Scholar
PubMed
Department of Pharmaco-Biology, Centro Sanitario, Department of Cellular Biology, Faculty of Pharmacy, University of Calabria, 87036 Arcavacata di Rende (Cosenza), Italy
Department of Pharmaco-Biology, Centro Sanitario, Department of Cellular Biology, Faculty of Pharmacy, University of Calabria, 87036 Arcavacata di Rende (Cosenza), Italy
Search for other papers by S Andò in
Google Scholar
PubMed
decades ( Liu et al . 2001 ). More than 95% of thyroid carcinomas are derived from follicular epithelial cells, while a minority of tumors (2%) is referred as undifferentiated or anaplastic carcinoma, one of the most aggressive human malignancies ( Kondo
Search for other papers by Silvana Libertini in
Google Scholar
PubMed
Search for other papers by Antonella Abagnale in
Google Scholar
PubMed
Search for other papers by Carmela Passaro in
Google Scholar
PubMed
Search for other papers by Ginevra Botta in
Google Scholar
PubMed
Search for other papers by Sara Barbato in
Google Scholar
PubMed
Search for other papers by Paolo Chieffi in
Google Scholar
PubMed
Search for other papers by Giuseppe Portella in
Google Scholar
PubMed
Introduction Anaplastic thyroid carcinoma (ATC) is one of the most aggressive human malignancies, responsible for up to 40% of mortality from thyroid cancer. Although multimodality treatments are successfully applied for well-differentiated thyroid
Search for other papers by D Giuffrida in
Google Scholar
PubMed
Search for other papers by H Gharib in
Google Scholar
PubMed
BACKGROUND
Clinically evident cardiac metastases from malignant neoplasms are uncommon. The frequency of thyroid metastasis to the heart is very low. To our knowledge, over the last 20 years only a few cases have been reported in the entire literature. Metastatic cardiac involvement occurs most often during the terminal stage.
PATIENTS
We present three cases of anaplastic thyroid cancer with metastatic involvement of the heart.
RESULTS
Two of the patients died from cardiac problems. The absence of early symptoms makes the clinical diagnosis of metastatic carcinoma difficult.
CONCLUSIONS
Anaplastic thyroid cancer is an aggressive cancer with a dismal prognosis. It should be borne in mind as a source of cardiac metastasis and a cause of cardiac death.